CLINICAL_TRIALS
research
· 2012-06-20
Clinical Trial Update: Citriodiol® and Impetigo [Phase 2, Phase 3]
Summary
This document reports an ongoing Phase 2/Phase 3 trial of Citriodiol® for impetigo, with the trial status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royal North Shore Hospital | Conditions: Impetigo | Phase 2, Phase 3 | Status: UNKNOWN